These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23216584)

  • 1. Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2013 Feb; 38(1):48-55. PubMed ID: 23216584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Eur J Pharm Sci; 2014 Jan; 51():26-33. PubMed ID: 23999037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    J Am Soc Hypertens; 2013; 7(1):32-9. PubMed ID: 23321403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Expert Opin Drug Saf; 2013 Sep; 12(5):621-9. PubMed ID: 23815562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial.
    Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
    Medicine (Baltimore); 2016 Mar; 95(13):e3084. PubMed ID: 27043671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
    Bilo G; Koch W; Hoshide S; Parati G
    Hypertens Res; 2014 Sep; 37(9):836-44. PubMed ID: 24942766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Inflammation; 2014 Feb; 37(1):154-62. PubMed ID: 24018781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients.
    Schmieder RE; Böhm M
    J Hum Hypertens; 2011 Jun; 25(6):354-63. PubMed ID: 20686499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
    Martinez-Martin FJ; Rodriguez-Rosas H; Peiro-Martinez I; Soriano-Perera P; Pedrianes-Martin P; Comi-Diaz C
    J Hum Hypertens; 2011 Jun; 25(6):346-53. PubMed ID: 21107432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; Fogari E; D'Angelo A; Cicero AF
    Hypertens Res; 2010 Aug; 33(8):790-5. PubMed ID: 20505674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S; Lee J; Karki S; Melino M
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG; Marbury TC; Robinson TD
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.
    Zhu JR; Zhang SY; Gao PJ
    Arch Pharm Res; 2014 Dec; 37(12):1588-98. PubMed ID: 25060946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D; Girerd X
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.